New on YCharts: We've added nearly 10,000 securities to our database with coverage of OTCMARKETS HIDE

Rockwell Medical (RMTI)

Create an Alert
4.05 +0.11  +2.79%   NASDAQ Jun 17, 8:00PM BATS Real time Currency in USD

Rockwell Medical R&D Expense Quarterly:

12.75M for March 31, 2013
View Full Chart

Rockwell Medical R&D Expense Quarterly Chart

    Rockwell Medical Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 12.75M
    Dec. 31, 2012 11.75M
    Sept. 30, 2012 16.24M
    June 30, 2012 10.88M
    March 31, 2012 9.406M
    Dec. 31, 2011 7.868M
    Sept. 30, 2011 4.221M
    June 30, 2011 3.314M
    March 31, 2011 2.403M
    Dec. 31, 2010 1.736M
    Sept. 30, 2010 0.728M
    June 30, 2010 0.4413M
    March 31, 2010 0.5174M
    Dec. 31, 2009 1.142M
    Sept. 30, 2009 1.978M
    June 30, 2009 1.997M
    March 31, 2009 1.338M
       
    Dec. 31, 2008 1.272M
    Sept. 30, 2008 0.9933M
    June 30, 2008 0.7817M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    RMTI R&D Expense Quarterly Benchmarks

    Companies
    Abbott Laboratories 346.32M
    Daiichi Sankyo
    Astellas Pharma

    RMTI R&D Expense Quarterly Rankings

    Overall 95th percentile
    700 of 16773
    Sector 87th percentile
    178 of 1408 in Healthcare
    Industry 82nd percentile
    24 of 135 in Drug Manufacturers - Major

    RMTI R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.4413M Jun 2010
    Maximum 16.24M Sep 2012
    Average 4.588M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');